Staley Capital Advisers Inc. Purchases 3,700 Shares of SPDR S&P Biotech ETF $XBI

Staley Capital Advisers Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,065 shares of the exchange traded fund’s stock after purchasing an additional 3,700 shares during the quarter. Staley Capital Advisers Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,307,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $256,053,000. Wells Fargo & Company MN boosted its stake in shares of SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp boosted its stake in shares of SPDR S&P Biotech ETF by 42,425.2% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Morgan Stanley grew its position in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares during the period. Finally, Assetmark Inc. grew its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $162.97 on Thursday. The firm has a 50 day simple moving average of $139.15 and a 200 day simple moving average of $130.89. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $164.35. The company has a market cap of $11.10 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.